|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Prepaids | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Property & equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued liabilities, related party | ||||||||||||||||||||
| Shares to be issued | ||||||||||||||||||||
| Convertible notes payable, net of discount - in default | ||||||||||||||||||||
| Convertible notes payable, net of discount | ||||||||||||||||||||
| Convertible bridge loans, at fair value | ||||||||||||||||||||
| Settlement liability | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Lease liability, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible notes payable, net of discount, long-term | ||||||||||||||||||||
| Lease liability, long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, $0.00001 par value; 5,000,000,000 shares authorized; 1,059,924,580 and 695,746,625 shares issued and outstanding at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Stockholders' deficits | ||||||||||||||||||||
| Series B Preferred Stocks | ||||||||||||||||||||
| Series A Preferred Stocks | ||||||||||||||||||||
| Total stockholders' deficits | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
| Preferred Stock, Value | ||||||||||||||||||||
| Preferred Shares Series A Member | ||||||||||||||||||||
| Preferred Shares Series B Member | ||||||||||||||||||||
| Series A Preferred Shares | ||||||||||||||||||||
| Series B Preferred Shares | ||||||||||||||||||||
Loading...
